Please login to the form below

Not currently logged in
Email:
Password:

Ashfield promotes Tom Mitchell to UK head of syndicated services

He first joined the UDG Healthcare division in 2008 as a regional business manager

Tom MitchellUDG Healthcare’s commercialisation service division Ashfield has appointed Tom Mitchell as head of syndicated services for the UK.

Mitchell joined the Ashfield commercial business in 2008 as its regional business manager (RBM) as part of the Apex syndicated team before taking on a role as project manager for the newly-formed Discovery syndicated team in 2010.

He said: “I am thrilled to be leading the development of our syndicated services, with so many highly skilled representatives in our established teams.

“The experience, productivity and in-call quality scores of our people mean clients can be proud to have them represent their brands.

“I look forward to working closely with our clients to further develop our syndicated sales solutions and the benefits that we can bring to their brands for many years to come.”

With over 28 years of experience, Mitchell has held numerous senior level roles such as medical representative, primary and secondary care RBM, and project manager among others.

Colin Watson, managing director of Ashfield, said: “Tom has a really important role to maintain our operational excellence, high quality sales calls, and close working partnership with our clients in order to deliver on their brand objectives.”

27th April 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Avalere Health

Avalere Health is a leading global commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Working from advisory to...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....